Answers are grounded in this paper and cite their sources.
first_page Download PDF settings Order Article Reprints Font Type: Arial Georgia Verdana Font Size: Aa Aa Aa Line Spacing: Column Width: Background: Open AccessAbstract From Function to Drug Discovery: Insights into Hypothetical Protein Rv1979c from Mycobacterium tuberculosis † by Mohamed Asif ShajahanMohamed Asif Shajahan SciProfiles Scilit Preprints.org Google Scholar * and Tamilvanan ThangarasuTamilvanan Thangarasu SciProfiles Scilit Preprints.org Google Scholar SRM DBT Platform, SRM Institute of Science and Technology, Chengalpattu 603203, India * Author to whom correspondence should be addressed. † Presented at the 3rd International Electronic Conference on Biomolecules, 23–25 April 2024; Available online: https://sciforum.net/event/IECBM2024. Proceedings 2024, 103(1), 69; https://doi.org/10.3390/proceedings2024103069 Published: 12 April 2024 (This article belongs to the Proceedings of The 3rd International Electronic Conference on Biomolecules) Download keyboard_arrow_down Download PDF Download PDF with Cover Download XML Download Epub Download Supplementary Material Versions Notes Keywords: Mycobacterium tuberculosis; drug discovery; phytochemicals; virtual screening; molecular dynamic simulation Mycobacterium tuberculosis is the causative agent of tuberculosis (TB), a highly contagious disease affecting millions of individuals globally. The emergence of drug resistance becomes a significant obstacle in the treatment of tuberculosis (TB). The Mycobacterium tuberculosis protein Rv1979c has been implicated in drug resistance, yet its function and potential inhibitors remain largely unexplored. In this study, we employed a comprehensive computational approach to unravel the role of Rv1979c and identify potential inhibitors from natural sources.This investigation was initiated by revealing the three-dimensional structure of Rv1979c via the threading/fold recognition method. Subsequently, a functional analysis of its molecular mechanism using a variety of computational tools yielded valuable insights. In addition, we screened a diverse collection of 11,708 phytochemicals against the Rv1979c target to identify potential inhibitors followed by molecular dynamic simulation. This exhaustive screening and simulation led to the identification of several prospective phytochemical candidates with significant binding affinity to the protein, indicating their potential as Rv1979c inhibitors.This interdisciplinary study combines computational biology and drug discovery techniques to cast light on the function of Rv1979c and reveal potential strategies for combating pathogenesis in M. tuberculosis. The findings provide a foundation for further experimental validation and the development of novel therapeutic agents to address the evolving challenges of TB drug resistance. Supplementary MaterialsThe following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/proceedings2024103069/s1, Conference poster.
No takes yet. Share an insight, caveat, or question.
Shajahan et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: